| Sadie R Goddard, | |
|
472 Ballaine Rd, Fairbanks, AK 99709-6550 | |
| (907) 712-7414 | |
| Not Available |
| Full Name | Sadie R Goddard |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 472 Ballaine Rd, Fairbanks, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558122432 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 203953 (Alaska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sadie R Goddard, 472 Ballaine Rd, Fairbanks, AK 99709-6550 Ph: (907) 712-7414 | Sadie R Goddard, 472 Ballaine Rd, Fairbanks, AK 99709-6550 Ph: (907) 712-7414 |
News Archive
Researchers at the University of Toronto have found that low-tech, inexpensive interventions for bedsores could improve health for long-term care residents and reduce health-care costs for the facilities that house them.
Suicide rates in those aged 10-19 in the UK declined by 28% in the seven year period from 1997-2003, shows a study published today in The Journal of Child Psychology and Psychiatry. The study, carried out by researchers at the University of Manchester, showed that the decline was particularly marked in young males, where rates declined by 35%.
Retinoblastoma protein RB1, which is named after a form of pediatric tumor of the eye, is among the most common genetically regulated cellular proteins to malfunction in human cancer. RB1 was also the first tumor suppressor gene to be identified and its modes of inactivation in retinoblastoma tumors provided the basis for the ground-breaking two-hit hypothesis by the geneticist Alfred G. Knudson in the 70s, according to which cancer is due to the accumulation of multiple 'hits' or mutations in certain genes.
Oceana Therapeutics, a global company focused on acquiring, developing and commercializing best-in-class specialty therapeutics, today announced that the U.S. Food and Drug Administration's (FDA) Gastroenterology and Urology Devices Panel recommended approval of Solesta™ as a treatment for fecal (bowel) incontinence, a condition afflicting many Americans, primarily women.
› Verified 5 days ago
Mrs. Kathleen Forehand Hall, CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1327 Kalakaket Street, Fairbanks, AK 99709 Phone: 907-452-4517 Fax: 907-452-4263 | |
Conversation Station Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 600 University Ave Ste 110, Fairbanks, AK 99709 Phone: 907-687-6309 | |
Ms. Heather E Eisenman, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1528 Bluegrass Dr, Fairbanks, AK 99709 Phone: 707-364-2013 | |
Kerry Rae Pippin, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 415 1st Ave, Fairbanks, AK 99701 Phone: 907-347-6494 | |
David Jamison, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1327 Kalakaket St, Fairbanks, AK 99709 Phone: 907-452-4517 | |
Mrs. Melinda Alexandria Mihalich, CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1327 Kalakaket Street, Fairbanks, AK 99709 Phone: 907-452-4517 Fax: 907-452-4263 | |
Mackenzee Heath, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 140 Chapman Ct, Fairbanks, AK 99709 Phone: 907-374-1686 Fax: 866-308-4995 |